This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schoeman, J. F. Articles by Hartzenberg, B. Search for Related Content PubMed PubMed Citation Articles by Schoeman, J. F. Articles by Hartzenberg, B. Social Bookmarking                         What's this?

Intractable Intracranial Tuberculous Infection Responsive to Thalidomide: Report of Four Cases

Departments of Paediatrics and Child Health and Neurosurgery, Tygerberg Children's Hospital and Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa, jfs{at}sun.ac.za.

Graham Fieggen, FCS SA

Department of Neurosurgery, Red Cross Children's Hospital, Cape Town, South Africa

Neil Seller, FCPaed SA

Departments of Paediatrics and Child Health and Neurosurgery, Tygerberg Children's Hospital and Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa

Marc Mendelson, PhD

Department of Infectious Diseases, Groote Schuur Hospital, Cape Town, South Africa

Bennie Hartzenberg, MMed

Departments of Paediatrics and Child Health and Neurosurgery, Tygerberg Children's Hospital and Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa

Paradoxical enlargement and development of new intracranial tuberculomas and tuberculous brain abscesses on adequate antituberculosis treatment are well recognized and supposedly cytokine mediated. These lesions are often unresponsive to conventional antituberculosis treatment, corticosteroids, and surgery. We therefore assessed the effect of adjunctive thalidomide, a tumor necrosis factor —modulating drug, in intractable intracranial tuberculosis that did not respond to standard medical and surgical therapy. Four consecutive children (three children with bacteriologic proof and one child with clinical evidence of intracranial tuberculosis) were studied. Three patients each had a giant tuberculous abscess, and the fourth had chronic basal arachnoiditis with progressive loss of vision. Three of the four patients had relentless neurologic deterioration, and all showed disease progression on neuroimaging despite full medical and appropriate surgical treatment. Marked clinical and neuroradiologic improvement occurred after thalidomide was added to the antituberculosis treatment regimen of these four patients. Adjunctive thalidomide might have a role in the management of intractable intracranial tuberculosis and needs further investigation in this regard. (J Child Neurol 2 0 0 6; 2 1: 3 0 1 — 3 0 8; DOI 10.2310/7010.2006.00071).

Journal of Child Neurology, Vol. 21, No. 4, 301-308 (2006)
DOI: 10.1177/08830738060210040801


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. C. Stefan, S. Andronikou, N. Freeman, and J. Schoeman Recovery of Vision After Adjuvant Thalidomide in a Child With Tuberculous Meningitis and Acute Lymphoblastic Leukemia J Child Neurol, February 1, 2009; 24(2): 166 - 169. [Abstract] [PDF]